tirzepatide cardiovascular outcome trial event risk assessment: a pre-specified meta-analysis CARDIOVASCULAR EFFICACY OF TIRZEPATIDE IN

Fibre-focused formulas can feel different in as few as three meals

NSAID use and risk of Parkinson disease: a population-based case-control study

There are two types of sclerodermas: juvenile systemic sclerosis (JSS), characterized by cutaneous and visceral involvement, and juvenile localized scleroderma (JLS), limited to the skin and underlying tissues [1]

Regular follow-ups allow clinicians to monitor progress, assess tolerance and make necessary adjustments to treatment or nutrition plans

BELIEVE is a phase 2, multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of intravenous bimagrumab and open-label subcutaneous semaglutide, alone or in combination, in adults with obesity or overweight plus at least one obesity-associated comorbidity